← Eichor
Study identifier: NCT06862128 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

OGTT at Home Using CGM vs at the Clinic

Condition: Pre-diabetes · Diabetes  ·  Sponsor: Linkoeping University

PhaseNA
Planned participants75
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This randomized, crossover study evaluates the feasibility and accuracy of a self-administered oral glucose tolerance test (OGTT) at home using continuous glucose monitoring (CGM) compared to a standard clinic-based OGTT. Participants with prediabetes will undergo both home-based and clinic-based OGTTs, with glucose levels measured via CGM and venous plasma glucose. The primary outcome is the correlation between CGM-based glucose values and standard OGTT results. Secondary outcomes include diagnostic agreement, metabolic hormone associations, and feasibility of home-based testing as a diagnostic tool for dysglycemia.

This description comes directly from the study's public registry record.

Talk to the study team

Peder af Geijerstam, MD, PhD  ·  +46739597426  ·  peder.af.geijerstam@liu.se

Always discuss trial participation with your own doctor first.

Locations (3)

Primary Health Care Center Bra Liv RosenhälsanHuskvarna, Jönköping County, SwedenRecruiting
Primary Health Care Center Cityhälsan CentrumNorrköping, Norrköping, SwedenRecruiting
Primary Care Center Vårdcentralen KärnaLinköping, Östergötland County, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06862128